Furosemide
Product Images NDC 66116-419

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 66116-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Furosemide Structural Formula (40eb0186 E55e 4f93 9233 996297910dbd 01)

Chemical structure diagram of the active ingredient Furosemide showing its molecular components including a chlorobenzene ring, sulfonamide group, carboxyl group, and furan ring.*

FDA Label Image

Furosemide 40mg Tablets (40eb0186 E55e 4f93 9233 996297910dbd 02)

Label for Furosemide Tablets, USP 40 mg by MedVantx, Inc., containing 30 tablets. The label includes dosage instructions to see the package insert, storage conditions at controlled room temperature (20°-25°C), and a caution to keep the container tightly closed and out of reach of children. It is marked as Rx Only and sample not for sale. The label also lists the manufacturer as Emcure Pharmaceuticals Ltd., India, and distributor as MedVantx, Inc., San Diego, CA. Additionally, there is a contact number for Teva Pharmaceuticals USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.